The glucagon-like peptide-1 receptor agonist, liraglutide, attenuates the progression of overt diabetic nephropathy in type 2 diabetic patients (Q86032588)
Jump to navigation
Jump to search
scientific article published on 01 September 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The glucagon-like peptide-1 receptor agonist, liraglutide, attenuates the progression of overt diabetic nephropathy in type 2 diabetic patients |
scientific article published on 01 September 2013 |
Statements
The glucagon-like peptide-1 receptor agonist, liraglutide, attenuates the progression of overt diabetic nephropathy in type 2 diabetic patients (English)
Shigeki Imamura
Keiji Hirai
1 September 2013